Interpharm services are unique in the extent of customization that the company performs to customer needs, and in its ability to reach all points of sale range in Gaza Strip health care and retail market.
Interpharm services are unique in the extent of customization that the company performs to customer needs, and in its ability to reach all points of sale range in Gaza Strip health care and retail market. Interpharm service a wide range of customers that include pharmacies, drugstore chains, health funds, hospitals and medical clinics. Interpharm succeeded to have an exclusive partnership agreements with many international companies.
AGUETTANT ESSENTIAL MEDICINES
Aguettant’s know-how covers the development, production and distribution of essential medicines. Medicines for emergencies, intensive care, anaesthesia and neurology: our broad experience in these therapeutic fields strengthens the reputation of Laboratoire Aguettant in hospitals day after day.
Altan Pharma LTD. is a specialty pharmaceutical company that develops, manufactures and markets injectable medications for the hospital and other provider segments. The company was founded with the strategic objective of building a premier, global injectable drug company that is committed to improving patient care by providing specialty medications of superior quality and value for the benefit of patients and caregivers.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
As one of the world’s leading medical technology companies, B. Braun aims to protect and improve the health of people around the world. For more than 180 years, we have shaped health care with our pioneering spirit and groundbreaking contributions.
Baxter International Inc.
For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen.
Decades ago, we searched for a name to set the tone for our company’s strategy and mindset. We chose to incorporate the word “Avenir,” French for “future”. As those of us in the pharmaceutical industry are well aware, nothing in this sector remain static or predictable. New technologies, new studies, and even new maladies all intersect with new regulations, policies and budgets to create a dynamic ecosystem and tracking these changes is a job almost unto itself. BioAvenir was established in 2001.
Bioindustria L.I.M. spa - Pharma Plant
Bioindustria Laboratorio Italiano Medicinali is constantly committed to the control of every phase of the production process to guarantee the quality, efficacy and safety requirements of its products.
Formed as a global pharmaceutical service & manufacturing platform in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides - Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
Fisiopharma was founded in 1989 as a result of an industrial project aimed to the production of drugs in the form of solutions, suspensions and powders for injection. Fisiopharma thanks to the experience and technology acquired in recent years, is continually engaged in research and development of new drugs. Fisiopharma collaborates with various Italian and foreign universities in the research and development of new production technologies for generic drugs market. To support the production the company has modern laboratories for chemical, physical and microbiological controls.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
Grindeks is the leading pharmaceutical manufacturer in Baltic States, headquartered in Riga, Latvia and operating since 1946. Over the years we have been recognized for helping millions of patients worldwide. Our products are sold in 103 countries globally. Grindeks product portfolio is successfully composed of original products, generics, and active pharmaceutical ingredients, all produced in line with the world-class requirements of safety and quality. To help people overcome their health issues, we focus on the heart and cardiovascular, CNS, anti-cancer, and anti-diabetes medicines. We aim to improve people's lives and make health solutions accessible to our patients.
hameln pharma is an owner-managed group of pharmaceutical companies whose products serve the well-being of patients, especially where quick help is urgently needed or even lifesaving. Our product range includes a wide range of injectable medicines for anaesthesiology and intensive care as well as palliative and emergency medicine.
Being a partner for contract manufacturing of pharmaceutical products (Contract Manufacturing Organization) in the field of: • Production of injectables in ampoules • Production of bulk tablets • Packaging of tablets • Quality control incl. batch release
IMUNA PHARM, a.s. with residence in Šarišské Michaľany is a Slovak company which operates in the pharmaceutical industry. The company´s focus is on pharmaceutical manufacture, which itself is subject to the application of highly demanding manufacturing processes and strict criteria set and upheld by the World Health Organization (WHO) and which are in accord with the legislature of the European Union. During the last 60 years of the company´s existence it has gone through a number of changes primarily in the field of technological development, the field of bussiness development and in the field of strategic activity. IMUNA PHARM has been a private company since 2002. In the last few years IMUNA PHARM, a.s has, through the usage of EU funds, modernised and renovated it´s capacities for production, thanks to which it has been able to create more opportunities and expand on to foreign markets.
One of the oldest pharmaceutical companies in the Baltic states Specializing in generics mostly for the hospital segment Key products: life–saving medicines, especially in the CNS and cardiovascular therapeutic group The company complies with the EU GMP requirements.
Kamada is a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, with a diverse portfolio of marketed products, a robust development pipeline and industry-leading manufacturing capabilities.
Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies. Kedrion was established in Italy in 2001, but the roots of the companies from which it was born stretch back several decades in the production of blood and plasma derived products. A primarily family-owned business, it places a high value not only on the welfare of those who benefit from its products but also on the people and communities where it operates.
Internationally, the laboratory has two subsidiaries, one in Portugal, Pharma Kern, and another one in the United States. In addition, the company carries out important export activities, manufacturing products for international laboratories and boosting internationalisation of its products through agreements with local distributors. Currently, Kern Pharma It is present in almost all the countries of the European Union.
Laboratorios Rubió was founded in 1968 by brothers Salvador and Pelayo Rubió, who were pharmacists by profession. They set out to market drugs which, as treatments for low-prevalence diseases, were unavailable in our country at the time. Laboratorios Rubió were pioneers in introducing important and life-changing drugs to Spain. Drugs such as a novel calcium-polystyrene-sulfonate preparation for the treatment of hyperkalaemia, or Rubifen, the first ADHD medication to be available in Spain, have played an essential role in improving survival rates and quality of life.
Beyond developing transformative medical therapies, we strive to make a difference for patients, by working to increase support to affected families and engaging with communities to create broader social acceptance of people living with brain diseases.
Lyomark Pharma was founded in Oberhaching, near Munich, in 1989 as a contract manufacturer and active ingredient manufacturer for niche products. As the name suggests, Lyomark supplies sterile lyophilised and liquid products, and has firmly established itself in this sector of the pharmaceutical industry over the last 25 years.
With health at the centre of our credo, we at Medinox care about people, enriching our customers’ journey with our innovative and affordable products, and pride ourselves on professional service. We believe that our passion for health is the core value that drives our team to ensure quality in every product we produce. Medinox manufactures and distributes a wide range of OTC health, wellness, beauty and consumer products to wholesalers, retailers and pharmacies around the world.
The journey has seen our active expansion into promising markets across the world – from our base in Europe, to the Middle East & Africa, through to the Far East and the Americas. Outside our 21 core offices, we developed a network of trusted agents and partners allowing us to operate in 107 countries.
We are uniquely positioned to deliver on our mission of empowering people worldwide to live healthier at every stage of life. As a global pharmaceutical company, improving access to sustainable and high-quality medicine is our relentless pursuit.
The Panpharma Group is recognised for its expertise in the development, production and marketing of injectable medicines for use in healthcare establishments. Since its creation, Panpharma has intentionally specialised in the field of injectable medicines to become one of its leaders. Its wide range of specialities covers the main therapeutic classes, with a particular focus on antibiotic therapy. Panpharma products are manufactured in accordance with the most demanding quality standards, generally at the Group production sites in France and Germany.
Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.
Piramal Pharmaceuticals Company
Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~$1.9 billion in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices. Piramal Foundation has initiatives in primary healthcare, nutrition, water, and social sector ecosystems.
We have been helping patients of all ages for 85 years. We create medicines for headaches, heartaches and those used in hospitals to save lives. We also enjoy the trust of doctors and pharmacists and work with them to help ensure healthy and long life for patients.
Laboratorio Reig Jofre
Founded in 1929 in Barcelona, Spain, REIG JOFRE is a pharmaceutical company listed on the Spanish Stock Exchange market, under the ticker RJF, dedicated to the research, development, manufacture and marketing of pharmaceutical products and food supplements. REIG JOFRE has more than 1,100 employees, 4 development and production centres in Europe (2 in Toledo, 1 in Barcelona and 1 in Sweden), subsidiaries in 8 countries (Spain, France, Portugal, Belgium, Sweden, United Kingdom, Poland, and Singapore) and 155 business partners in more than 70 countries.
Since 1921 S.A.L.F. S.p.A. Pharmacological Laboratory has been producing in its own factory in Cenate Sotto (BG) sterile solutions for injections for hypodermoclysis/phleboclysis, parenteral nutrition, irrigation, dialysis, anticoagulant solutions, solutions for organ preservation, anesthetics, analgesics, markers and many other drugs, thus covering a wide range of therapeutic categories. See Products
Established in 1921 and headquartered in Mendrisio, Sintetica is a Swiss pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing.
Sterop; your partner as subcontractor manufacturer for a large range of production. Sterop is constantly evolving, and is looking worldwide for strong and long-term partners possessing excellent marketing & sales culture to increase its presence in new international markets.
VUAB pharma a.s.
VUAB Pharma has extensive collaboration with universities and clinical centers enabling solutions to large and complex issue new, highly effective means for treatment of oncological diseases. The actual production of these substances is carried out in the factory in Brno, which also has the relevant certification entitling pharmaceutical production.
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.